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Abstract
Background: Management of hypertension in Mozambique is poor, and rates of control are amongst the lowest in
the world. Health system related factors contribute at least partially to this situation, particularly in settings where
there is scarcity of resources to address the double burden of infectious and non-communicable diseases. This
study aimed to assess the management of hypertension in an emergency department (ED).
Methods: During a pragmatic and prospective 30-day snapshot study (with 24 h surveillance) and random profiling of
one-in-five presentations to the ED of Hospital Geral de Mavalane, Maputo, we assessed patient’s flow and care, as well
as health facility’s infrastructure and resources through direct observation. Reports from pharmacy and laboratory
stocks were used to assess availability of diagnostics and medicines needed for hypertension management.
Results: The 1911 hypertensive patients included in the study had several stops during their journey inside the health
facility and followed a non-standardized care flow. No clinical protocols or algorithms for risk stratification of
hypertension were available. Stock-outs of basic diagnostic tools for risk stratification and medicines were registered.
The availability of medicines was 28% on average.
Conclusions: Critical gaps in health facility readiness to address arterial hypertension seen in ED were uncovered,
including lack of clinical protocols, insufficient availability of diagnostics and essential medicines, as well as low
affordability of the families to guaranty continuum of care. Innovative financing mechanisms are needed to support
the health system to address hypertension.
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Background
Hypertension is the leading risk factor for premature death
and disability and constitutes an important cause of health
services demand worldwide [1]. Global disparities in its
prevalence and awareness have been increasing [2, 3].
In Mozambique, hypertension prevalence is among the
highest in developing countries, and has increased in
people aged 25–64 from 33.1 in 2005 to 38.9% in 2015
(p 0.048) with low awareness (14.5%), treatment among
those aware (50.1%) and control among the treated
(44.5%) [1, 4]. Hypertension is an important driver of
heart failure and stroke in this country [5, 6] and thus
constitutes a priority in Mozambique’s strategic plan for
non-communicable diseases (NCD) prevention and con-
trol [7]. However, the national health information system
still does not systematically perform surveillance of
hypertension and its complications.
Initial surveillance data on NCD targeted by the World
Health Organization (WHO) global strategy for the pre-
vention and control of NCD showed prominence of
hypertension as a cause of poor outcomes [8]. Due to
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the continuing need for major efforts to control infectious
endemic diseases in Mozambique, the burden imposed by
NCD constitutes a high risk for the sustainability of the
health system. Moreover, because no funding mechanisms
are available to sustain national NCD program’s activities
within the National Health Service (NHS) in Mozambique,
insufficient investments have been made on health facilities
to address this double burden of disease. Our study aimed
at describing care provision for hypertensive patients
assisted at the emergency department (ED) of a first-
referral urban hospital, often an entry point for patients
into the NHS.
Methods
The National Health System in Mozambique comprises
the public sector, the for-profit private sector, the non-
profit private sector and the community sector. The
public sector, which is the National Health Service
(NHS), is the main provider of health services on a na-
tional scale, and is organized into four levels of care (pri-
mary - health centres; secondary – district hospitals and
general urban hospitals; tertiary – provincial hospitals;
quaternary – specialized and sub-specialty hospitals).
Treatment and diagnostic resources for the NHS de-
pends on a supply chain structured in 5 levels. The Cen-
tral Level with three regional warehouses for Southern,
Central and Northern Region supplying central and gen-
eral hospitals and provincial deposits; the Provincial
Level with provincial deposits supplying tertiary and
lower level facilities, including some rural hospitals and
district health centers; the District Level deposits supply-
ing all health facilities in one district. Pharmacies in
health centers and community Health Workers - sup-
plied by the nearest district deposits or health centers –
constitute the primary and community levels, respect-
ively [9]. Levels of prescription have been defined to en-
sure that each health professional prescribes according
to their training background and the health facility level
[10]. Care cost is $0.02 (1MZN) per appointment, nil for
complementary exams and $0.08 (5MZN) for each pre-
scription with one or more medicines. The total amount
charged corresponds to 0.14% of the patient’s salary,
considering the official minimum wage [11].
Setting
We performed an assessment of hypertension care in
patients assisted around the clock at a first-referral hos-
pital in Mozambique’s capital city - Hospital Geral de
Mavalane (HGM). This is an urban secondary level
265-bed hospital serving a population of nearly 800,
000; it is a pilot sentinel site for NCD without patient
electronic management system, and where hospital
identification cards and medical files are used for pa-
tients with chronic condition.
Sampling
During the pilot-phase of the MOZambique snApshot of
emeRging Trends (MOZART) Disease Surveillance Study
cohort [12], with a target of at least 1000 patients per
health facility studied, and based on previous knowledge of
the caseload of patients in the hospital a ratio of selected
presentations of 5 to 1 was established to achieve this mini-
mum target. Over 30 consecutive days with 24-h coverage
patients of any age presenting to the emergency depart-
ment of the HGM were registered and randomly selected
for a more detailed profiling. Selected participants were
approached by trained staff for informed consent; the first
patient to be selected during each shift was selected ran-
domly (from a list of the first five patients assisted); then,
every fifth patient would be invited to participate. If a ran-
domly selected patient was unable to respond to the nurses
or the study survey team (i.e., unconscious, confused due
to mental illness, severely ill, or under the influence of
illicit drugs) informed written consent, demographics and
risk factors data (including arterial hypertension), were ob-
tained from a family member or spouse (legal guardians)
by a medically qualified researcher. Even if the patient was
not included in the study, he/she would be registered
through the usual health information system, and therefore
included in the full count of patient activity during the 30-
day snapshot period.
Data collection
For each patient presenting at the ED pre-designated
data collection was performed by trained personnel, with
skills for health surveillance and/or medical and nursing
qualifications, using electronic capture. Direct observa-
tion was done using several trained health workers in
each station and registered in paper-based case report
forms (CRF) for full registry of the patient’s profile
(name, residential suburb, contact details and hospital
identification, demographics, risk factor’s data, medical
history, clinical data, management information, immedi-
ate outcomes and time of discharge); researchers from
INS entered data in electronic CRF on dedicated study
laptops with restricted access ensuring the anonymity of
each patient. Those patients admitted to wards or trans-
ferred to an elective unit were followed-up through their
hospital records for the later completion of management
and outcome data. At the completion of data collection,
each case was allocated a final ICD 10 diagnosis (a web-
link providing access to all ICD-10 coding for reference
is provided). Participants were given a unique identifier
to protect their anonymity and only de-identified data
were used to generate study findings. Elevated BP was
defined by systolic ≥140 mmHg and/or diastolic BP ≥90
mmHg (Grade I) - for adolescents above 15 years and
adults (≥20 years); grade II hypertension 160–179 and/or
100–109 and grade III ≥ 180 and/or ≥ 110 [13].
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To describe the management of hypertension we used
direct observation of patient’s flow during the study, in-
cluding collection of data on the infrastructure and human
resources. Using the Package of Essential NCD interven-
tions for primary health care in low-resource settings
(PEN) [14] we selected diagnostic tools and medicines that
are needed for hypertension management; we then con-
sulted the reports from pharmacy and laboratory stocks to
assess availability of diagnostics and medicines. The WHO
essential medicines target of 80% was used to define avail-
ability. To define affordability the patient monthly capacity
to purchase a medicine, we considered the national mini-
mum wage and the WHO/HAI external reference pricing
(available at the WHO/HAI database of medicine prices,
availability, affordability and price components) [15] to
calculate the number of work days, as well as the percent-
age of the monthly minimum wage that a patient needs to
obtain the medicines prescribed.
Data analysis
Data was analysed using descriptive statistics (percent-
ages and proportions); patient’s flow in the health facility
and availability/affordability are presented graphically.
Ethical issues
We have followed the STROBE guidelines for the con-
duct and reporting of observational studies [16]. The
study had ethical approval by the National Bioethics
Committee in Mozambique (IRB 0002657). Informed




Out of the 8890 patients assisted during the study period
we selected 1911 cases, of which 14 refused to participate
and 55 were lost to follow up. For 197 patients data was
incomplete. Among the remaining 1645 patients, 556 were
children under 10 who were excluded from analysis. Of
the remaining 1089 patients, 28 patients did not have their
blood pressure measured and thus were excluded from
analysis and 47 had the diagnosis of hypertension but the
attending health worker had not registered the blood pres-
sure values. Thus, 1014 patients were included in the ana-
lysis - 574 (56.6%) females, 263 (16%) adolescents (10–19
years) - of which 322 had high blood pressure; among
these, 26 (2.6%) were adolescents > 15 years. Of the 322
hypertensive patients (females 168, 52.2%), 68 presented
with systolic blood pressure ≥ 160mmHg and/or diastolic
blood pressure ≥ 100mmHg. From these hypertensive pa-
tients 37 were transferred to the hospital’s intensive care
unit, 6 (2%) were admitted to hospital wards, and 3 (1%)
needed transfer for specialized care in referral hospitals
due to acute complications.
Patient flow
Hypertensive patients had several stops during their
journey inside the health facility. After initial triage at
entry they could be sent directly to the ICU in case of
hypertensive emergency/crisis. All other cases would
wait for doctor’s evaluation, blood collection for bio-
logical profiling at the laboratory, eventually performing
chest X-ray and, finally, returning the results to the
assisting doctor, who would decide if they were sent to
the ICU, transferred to a specialized hospital, admitted
to the wards or discharged. (Fig. 1).
Facility resources
Basic clinical equipment for diagnosis was available
(sphygmomanometers, scales/altimeters, oxymeters, elec-
trocardiograph, X-ray machine and ultrasound). However,
no rapid tests were available (urine, blood glucose or
HbA1c) for prompt risk stratification, and occasional
stock-outs were registered for cholesterol and uric acid.
Regarding human resources availability, the hospital had
38 general practitioners working around the clock at the
ED who assisted patients and took decisions on: admitting
them to the intensive care unit or transfer them to a refer-
ral hospital; admitting them into the hospital wards; send-
ing them to book appointments for outpatient clinic for
follow up with specialists within the hospital; or send
them to a satellite health centers and the ED. There was
no variation in availability of clinicians and other personal
during the 24 h. The staff of the whole hospital is pre-
sented in Fig. 2. No guidelines for risk stratification of
hypertension were available in the consultation rooms,
nor were manuals or algorithms.
Availability & Affordability of medicines
The availability of medicines was 28% on average; 3 to 6%
for calcium channel blockers (amlodipine) and aldosterone
antagonist (spironolactone), respectively; between 51 to
70% for adrenergic modifier/alpha-2 agonist (methyldopa),
loop diuretic (furosemide) and angiotensin converting en-
zyme inhibitor (enalapril); only nifedipine 30mg was avail-
able in reaching the WHO essential medicines availability
target of 80% (availability 145%). Beta-blockers,
angiotensin-II receptors antagonists, angiotensin converting
enzyme inhibitor (lisinopril) and the combination (Hydro-
chlorothiazide and Amiloride) had 0% availability during
the study period (Table 1). For medicines not available at
the health facility pharmacy patients would spend from 0,
5–11.2% of their monthly wage to purchase a single medi-
cine, corresponding to 0,2–3,4 work days. The most afford-
able medicines found in this context were
Hydrochlorothiazide, Methyldopa, Atenolol and Furosem-
ide. The later - used to treat hypertension complications -
was the most affordable medicine, while Nifedipine
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corresponded to 11.2% of the monthly minimum wage, ap-
proximately 3.4 work days. (Fig. 3).
Discussion
This study unveils a high occurrence of severe hypertension
in patients assisted at the emergency department of this
first urban hospital, in a context of health facility barriers to
good quality of care for hypertensive patients, particularly i)
the lack of availability of guidelines and clinical protocols
for management for use by health professionals; ii) the ab-
sence of standardized risk stratification, follow up and refer-
ral; iii) deficient strategies to ensure continuum of care; and
iv) low availability of key consumables for laboratorial diag-
nosis and medicines. These organizational weaknesses in-
crease the risk of poor outcomes, particularly in patients
already with complications, or in those who have grade se-
vere hypertension and/or associated risk factors.
Recently, a clinical study from the same health facility re-
ported on poor short-term outcomes of severe and compli-
cated hypertension [17]. In this report, young adults with
high-risk profile and multimorbidity had high case-fatality,
occurrence of established and/or de novo target organ
damage, and hospitalisation rates on six-month follow-up.
Additionally, this hospital cohort had low control rates and
a concerning pattern of multimorbidity (more than two co-
existing chronic conditions) that significantly increase the
pressure on already stretched health systems.
Mozambique’s low rates of medical doctors and trained
specialists [18, 19] - as well as nurses and allied profes-
sionals - are among the lowest in the world. To address
the lack of workforce to tackle endemic infectious diseases
(such as malaria, tuberculosis, HIV/AIDS and neglected
parasitic diseases) the NHS has accommodated health
professionals with basic- and mid-level training who are
trained for triage and management of simple cases, using
algorithms for diagnosis, management and referral [20]
Most of these clinical guidelines are recommended or en-
dorsed by the WHO, and are easily incorporated in the
health systems due to being largely subsidized by inter-
national funding organizations. In contrast, for NCD clin-
ical protocols and management algorithms are still not
consensual, and rarely used in our setting, despite their
known role in improving the quality of care. While recog-
nizing that the number of health professionals is reduced,
lack of risk-based management, unavailability of standard
evidence-based clinical protocols and low access to essen-
tial anti-hypertensive drugs [21] – all essential to ensure
high quality of care and prevent complications - are major
Fig. 1 Flow of Patients. Describes the flow of the patient with hypertension from arrival at the ED to discharge, indicating the number of
hypertensive patients that were seen during the MOZART study
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gaps in hypertension care. Addressing these gaps would
allow standardization of care provided by front-line health
workers and probably improve outcomes in secondary
level health facilities. Indeed, the fact that hypertension-
related complications have become more diagnosed at
secondary and tertiary care levels in some settings in Af-
rica, is probably indicative of poor management of hyper-
tensive patients at primary health care level.
Because ED in low-income settings are often the first
contact point of patients with the health system, strategies
to reduce lost opportunities for early diagnosis, prompt
management and secondary prevention are needed. ED
may be the only or most used form of contact with the
health system for certain population groups in our health
system, particularly adolescents and men who are not cov-
ered by the strong maternal and child health care pro-
grams. Owing to the high prevalence of hypertension in
Mozambique [4], point-of-care diagnostics tools – for in-
stance rapid testing for biomarkers, portable electrocardi-
ography and bedside ultrasound –should be used to
facilitate risk stratification, detection of co-morbidities and
identification of complications such has heart failure and
kidney disease. In addition, clinical protocols must be
made available to allow immediate treatment of those at
high risk of target organ damage. Moreover, despite recog-
nizing that ED are not the ideal setting for patient health
education, counseling on healthy lifestyle, risk-free behav-
ior and adherence to therapy to selected populations
should probably be considered in such setting, to avoid
loss of opportunities to prevent complications, to reduce
hypertension-related morbidity and mortality, as well as to
support continuity of treatment after diagnosis. The use of
preventive medicine health workers - who are currently
involved in maternal and child health disease prevention –
would probably be an important step towards better con-
trol of hypertension, if these professionals are trained to
provide counseling and non-pharmacological therapy in-
side the health facility.
Inadequate supply of medicines is a major determinant
for inadequate anti-hypertensive treatment and cata-
strophic spending in poor households and may (at least
partially) explain the low levels of control in Mozambique
[4, 6, 22]. Access to public hospitals is virtually free; pa-
tients pay $0.02 at entry points for all procedures within
Fig. 2 Human Resources Availability. The distribution of health professionals involved in patient care and administrative roles in this health facility
is presented, including personnel allocated to NCD complementary services. The numbers are shown per type of services needed
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the health facility and $0.08 per full prescription, the total
amount charged corresponding to 0.1% of the country’s
minimum wage [11]. However, out-of-pocket expenditure
for continuum of care in hypertension may be prohibi-
tively expensive for the poorest households, as communi-
ties have high levels of poverty and informal employment,
and almost no access to affordable private health insur-
ance mechanisms. In Bangladesh, NCD-afflicted families
allocate a greater share of household expenditures for
medical care than households without NCDs and have
almost seven times higher probability of incurring cata-
strophic medical expenditure, as well of selling assets or
borrowing from informal sources to finance treatment
cost [23]. In Mozambique, a considerable proportion of
the household budget for families living on the national
minimum wage is used to buy any anti-hypertensive,
mainly if the patient needs more than one hypertensive
medicine. Medical therapy entails large out-of-pocket ex-
penditures and increases the likelihood of household im-
poverishment as shown in Kyrgyzstan, where households
Table 1 Hypertension Medicines Availability. Drugs and formulations prescribed to patients with hypertension, its estimated need
and availability in the hospital

















0,5 7905 0% < 80%
Angiotensin Converting
Enzyme Inhibitor
Lisinopril Tablets 20 mg 1 15,810 0% < 80%
Calcium Channel Antagonists Nifedipine Tablets 30 mg 1 15,810 145% > 80%
Calcium Channel Antagonists Nifedipine Tablets 60 mg 1 15,810 0% < 80%
Beta blocker Bisoprolol Tablets 5 mg 1 15,810 0% < 80%
Beta blocker Atenolol Tablets 50 mg 0,5 7905 0% < 80%
Angiotensin-II Receptor
Antagonist
Irbesartan Tablets 300 mg 1 15,810 0% < 80%
Angiotensin Converting
Enzyme Inhibitor
Enalapril Tablets 20 mg 1 15,810 60% < 80%
Adrenergic modifier
/ alpha 2 agonist
Methyldopa Tablets 250 mg 1 15,810 51% < 80%
Aldosterone antagonist Spironolactone Tablets 25 mg 1 15,810 6% < 80%
Loop diuretic Furosemide Tablets 40 mg 1 15,810 70% < 80%
Obs: The availability was calculated for all patients (527) reported to have hypertension assisted in October 2017 (considering that this number includes the
patients transferred from the ED, and medication should be available for all of them). SDG EM: Sustainable Development Goals Essential Medicines
Fig. 3 Work days & Affordability of Medicines. The medicines selected corresponded to the different lines of treatment for arterial hypertension
and its complications prescribed at a first-referral hospital according to the national medicines formulary. The graph presents data on affordability
of anti-hypertensive drugs (when obtained outside the health facility)
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with an hypertensive patients had significantly higher total
expenditure on health and drug therapy, thus being more
prone to catastrophic health spending [22]. Similarly, it
has been shown that patient costs associated with obtain-
ing care for hypertension in public health care facilities in
Kenya include substantial direct and indirect costs, as well
as high rates of catastrophic costs [24]. Therefore, systems
to assess the unmet needs of anti-hypertensive drugs, im-
prove the whole supply chain in the public sector and fi-
nancial risk protection for patients from these poor
communities are needed.
Health System related factors impact on the capacity
to control blood pressure [25–27] In African countries
Health Systems are primarily oriented to managing in-
fectious diseases, and therefore health professionals are
unprepared to deal with NCD, given the scarcity of re-
sources in health facilities [28]. The strategy of task-
shifting - defined as the rational distribution of health
care duties from physicians to non-physicians health
care providers - is one of the effective approaches that
has been used to address lack of human resources in Af-
rica [29], including for management of HBP [30, 31].
Considering the experience of Mozambique’s NHS in
task shifting in obstetrics, surgery and mental health [20,
32], we strongly believe that targeted context-specific
changes to the Health System in Mozambique can also
be done to allow task-shifting for the diagnosis and
management of hypertensive patients to occur, in order
to improve rates of control and outcomes.
Limitations: Despite the acknowledging that the “snap-
shot” taken during one month cannot be fully represen-
tative of the situation, we believe that this description of
hypertension care in ED constitutes an initial step to-
wards addressing poor outcomes and understanding the
organizational changes needed to improve care in our
setting. Moreover, this model can be ameliorated and
replicated for assessment of health care for other risk
factors and NCD, thus supporting priority setting and
selection of the most efficient interventions and health
services changes that can be done to create context-
tailored NCD clinics in Africa.
Conclusions
Critical gaps in health facility readiness to address arterial
hypertension seen in ED were uncovered in this highly
prevalent low-income urban setting, including lack of clin-
ical protocols, insufficient availability of diagnostics and
essential medicines, as well as low affordability of the fam-
ilies to guarantee continuum of care. Our results show op-
portunities for improvement at the provider’s level,
particularly of the organizational and managerial pro-
cesses. Innovative financing mechanisms for the health
system are needed to support the poorest, improve the
rates of hypertension control and prevent poor outcomes.
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